NewslettersHematopoiesis NewsA Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients With MyelofibrosisBy Jamie Kang - July 18, 2023073Researchers conducted an investigator-initiated, multicenter, Phase Ib trial of AVID200 monotherapy in 21 advanced myelofibrosis patients.[Clinical Cancer Research]Abstract